Explore the fierce competition between Novo Nordisk and Pfizer as they vie for Metsera amidst a booming obesity drug market.
Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...
Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer as the ...
46mon MSN
Word of the day: Equivocal
The word \"equivocal\" originates from Latin, meaning \"of equal voice,\" signifying ambiguity and multiple interpretations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback